| Nov 21 |
BioVie files to sell 7.71M shares of common stock for holders
|
| Nov 20 |
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
|
| Nov 4 |
BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded
|
| Oct 31 |
(BIVI) - Analyzing BioVie's Short Interest
|
| Oct 29 |
BioVie Inc. Announces Closing of Registered Direct Offering
|
| Oct 28 |
UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
| Oct 28 |
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
| Oct 23 |
BioVie Announces Stock Offering and Private Placement
|
| Oct 23 |
Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024
|
| Oct 22 |
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement
|
